Aequim Alternative Investments LP Bausch Health Companies Inc. Transaction History

Aequim Alternative Investments LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$6.09 - $7.93 $60,900 - $79,300	-10,000 Reduced 25.0%	30,000 $188,000
Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $45,800 - $92,100	10,000 Added 33.33%	40,000 $276,000
Q4 2021 Feb 09, 2022	BUY	$23.0 - $29.01 $690,000 - $870,300	30,000 New	30,000 $828,000
Q2 2021 Aug 13, 2021	SELL	$27.43 - $32.7 $356,590 - $425,100	-13,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$15.31 - $21.12 $486,858 - $671,616	-31,800 Reduced 70.98%	13,000 $270,000
Q4 2020 Feb 10, 2021	BUY	$15.31 - $21.12 $486,858 - $671,616	31,800 Added 244.62%	44,800 $403,000
Q1 2020 May 15, 2020	BUY	$12.98 - $30.25 $168,740 - $393,250	13,000 New	13,000 $202,000
Q4 2019 Feb 14, 2020	SELL	$18.89 - $31.89 $629,037 - $1.06 Million	-33,300 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$17.64 - $28.32 $587,412 - $943,056	33,300 New	33,300 $615,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Aequim Alternative Investments LP, based on Form 13F filings with the SEC.

Stay updated on Aequim Alternative Investments LP with notifications on news.